Date: Friday April 4th - 5th,  2025
Time:  05:00 PM – 8:30 PM and 07: 45AM - 3:45 PM
Location: Crowne Plaza Houston Med Ctr-Galleria Area, 2712 Southwest Fwy, Houston, TX 77098.
Parking: Onsite, Self-parking

Conference Objectives:
1. Discuss the integration of genomic and molecular testing results to personalize treatment approaches in hematologic malignancies
2. Evaluate the efficacy and safety profiles of emerging immunotherapies, including bispecific antibodies and CAR-T therapies
3. Analyze barriers to stem cell transplant accessibility and implement strategies to improve equitable donor matching
4. Assess the landscape of novel drug development in hematologic malignancies and incorporate new therapeutic options into clinical practice
5. Discuss techniques to navigate grief and foster gratitude as a means of enhancing resilience in oncology practice

Accreditation Statement/Available Credits
CME:
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The University of Texas Medical Branch and Lone Star Oncology. The University of Texas Medical Branch is accredited by the ACCME to provide continuing medical education for physicians.

Physician Credits
UTMB CME designates this live activity for a maximum of 7.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CNE/NCPD Lone Star Oncology is approved as a provider of nursing continuing professional development by Louisiana State Nurses Association - Approver, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.

REQUIREMENTS FOR SUCCESSFUL COMPLETION:
To receive contact hours for this nursing continuing professional development activity, the participant must:
 - Sign in.
 - Attend and be present for the entire presentation. No partial credit will be provided.
 - Complete the evaluation after the presentation via a link provided to all participants.
 - Certificates will be awarded electronically upon completion of the evaluation.
 - Once successful completion has been verified, a “Certificate of Successful Completion” will be awarded for 7.5 NCPD contact hours and 2.5 Pharmacotherapeutic contact hours.

Faculty/Speakers

Friday April 4th 2025

4:45 PM:  Registration/Networking/Exhibit Open

5:15 PM:  Welcome/Registration/Networking

6:00 PM:  Genomics, Testing  & Cancer Prevention - Afton Dickerson MSN, AGACNP-BCP, CBCN, AOCNP, CGRA Oncology Consultants

7:00 PM:  Therapy Updates and Key Development in Hematology Oncology - Karen Abboud PharmD, BCPS, BCOP Pharmacy Clinical Specialist- Hematology/Oncology Houston Methodist

8:00 PM:  Networking

Saturday April 5th 2025

7:30 AM:  Breakfast/Registration/Networking

7:55 AM:  Attendee Information

8:00 AM:  Acute Leukemias: Clarifying and Achieving the Goals of Care - Sara Taveras MD Assistant Professor, Hematology Medical Oncology, UT Health Houston McGovern Medical School.

8:45 AM: Managing Hematologic Emergencies - Rizza Macas, MSN, APRN, FNP-C Supervisor, Advanced Practice Provider MD Anderson Cancer Center

9:30 AM:  Break/Networking

9:40 AM:  Stem cell Transplant: Bridging the Gap and Addressing Disparities in Donation - Warren Fingrut MD Assistant Professor, University of Texas MD Anderson Cancer Center

10:25 AM:  Myelodysplastic Syndromes ( MDS) & Myelofibrosis (MF) - Tareq Mazen Izzeddin Abuasab Assistant Professor Baylor College of Medicine

11:05 AM Break

11:15 AM:  Multiple Myeloma: The New Era of Bi-specific Antibodies in the Management and Treatment of Multiple Myeloma - Adan Rios MD Director, Malignant Hematology Section, Oncology Division, Department of Internal Medicine. UT Health Houston McGovern Medical School.

12:00 PM Break/Lunch/Networking

1:15 PM: Well-Being Expedition: Caring for the Oncology Professionals - Roselyn Ogunkunle PhD, MSN, RN, NEA-BC, OCN, CReC

2:00 PM: Advances and Patient Management in Lymphomas - Sai Pingali, MD Associate Professor Houston Methodist Neal Cancer Center

2:45 PM: Break/Networking

3:00 PM: Gratitude and Grief Expression for Oncology Professionals - Lauren Delumpa MSN, RN, FNP-C Assistant Professor University of St. Thomas, APRN UTHealth Houston

3:45 PM: Conference Conclusion Information/Evaluation

Planners

Maribel M. Marquez-Bhojani, DNP, RN, NPD-BC - Nurse Planner, Nothing to Disclose
Debbie Mitchell, MSN, RN, CCRN, NE-BC, OCN - Planning Team, Nothing to Disclose
Shelita Anderson, DNP, MBA, RN, NEA-BC - Planning Team, Nothing to Disclose
Diem Chu MMS, PA-C- Planning Team, Nothing to Disclose
Roselyn Ogunkunle PhD, MSN, RN, NEA-BC, OCN - Planning Team, Nothing to Disclose

To exhibit at this program, please email info@daaronfoundation.org
All industry partners attending as attendees must register to attend and abide by all applicable compliance regulations

Thank you Sponsors & Exhibitors!

Diamond
 - AbbVie  PharmaEssentia   Immunocore  Syndax Pharmaceuticals

Gold
 - Merck & Co. Inc.  Pfizer  Sobi North America  Novartis Pharmaceuticals   Agios Pharmaceuticals
 - Sobi  Daiichi Sankyo, Inc.   Sanofi (Rare Disease)

Silver
 - Amgen  Incyte Corporation  Menarini Stemline  Sanofi  Astellas  PCYC  
 - Apellis Pharmaceuticals  AstraZeneca  Biologics by McKesson  Sanofi  Johnson and Johnson 
 - Merck & Co.   Ricordati  Rigel   ADC Therapeutics 

Past Program Sponsors & Exhibitors 

Sobi  North America - Podium sponsor
AbbVie - Podium Sponsor
AstraZeneca

Merck Hematology
Novartis
Daiichi Sankyo, Inc.
PharmaEssentia USA Corporation
Jazz Pharmaceuticals, Inc.
BeiGene
BMS
Biologics by McKesson
Manor Specialty Pharmacy
Merck Nursing Education